{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042927","form_type":"8-K","ticker":"MIRA","cik":"0001904286","company_name":"MIRA PHARMACEUTICALS, INC.","filed_at":"2026-09-16T20:30:24+00:00","discovered_at":"2026-09-16T20:31:20.125338+00:00","generated_at":"2026-09-16T20:31:35.452501+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"MIRA shareholders elect five directors and ratify auditor at 2026 annual meeting","bullets":["At Sept 11, 2026 annual meeting, 26,499,076 shares voted (63.06% quorum); five directors elected.","Erez Aminov, Matthew Whalen, Matthew Del Giudice, Denil Shekhat, Edward MacPherson elected with ~20.1-20.6M votes each.","Ratification of Salberg & Company as auditor for FY2026 passed: 25,950,852 for, 158,064 against, 390,160 abstain.","Adjournment proposal approved: 24,897,741 for, 1,205,307 against, 396,028 abstain.","Record date was July 21, 2026; 42,022,087 shares outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042927","json":"https://secwatch.observer/filing/0001493152-26-042927.json","markdown":"https://secwatch.observer/filing/0001493152-26-042927.md","text":"https://secwatch.observer/filing/0001493152-26-042927.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226042927/0001493152-26-042927-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226042927/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-16T20:31:35.452501+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}